Wells Fargo & Company Pfizer Inc Transaction History

Wells Fargo & Company

$434 Billion
Q3 2024

A detailed history of Wells Fargo & Company transactions in Pfizer Inc stock. As of the latest transaction made, Wells Fargo & Company holds 20,960,519 shares of PFE stock, worth $523 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

20,960,519

Previous 21,263,304 1.42%

Holding current value

$523 Million

Previous $595 Million 1.96%

% of portfolio

0.14%

Previous 0.15%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $8.39 Million - $9.5 Million	-302,785 Reduced 1.42%	20,960,519 $607 Million
Q2 2024 Aug 13, 2024	BUY	$25.26 - $29.6 $24.6 Million - $28.8 Million	974,008 Added 4.8%	21,263,304 $595 Million
Q1 2024 May 10, 2024	BUY	$25.89 - $29.73 $36.1 Million - $41.5 Million	1,394,910 Added 7.38%	20,289,296 $563 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $71.7 Million - $93.2 Million	-2,745,408 Reduced 12.69%	18,894,386 $544 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $38.2 Million - $44.7 Million	-1,191,054 Reduced 5.22%	21,639,794 $718 Million
Q2 2023 Aug 15, 2023	BUY	$36.12 - $41.79 $5.49 Million - $6.35 Million	151,886 Added 0.67%	22,830,848 $837 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $1.24 Million - $1.62 Million	31,503 Added 0.14%	22,678,962 $925 Million
Q4 2022 Feb 13, 2023	BUY	$41.75 - $54.5 $11 Million - $14.4 Million	263,442 Added 1.18%	22,647,459 $1.16 Billion
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $22.5 Million - $27.5 Million	-515,234 Reduced 2.25%	22,384,017 $980 Million
Q2 2022 Aug 12, 2022	SELL	$46.53 - $55.17 $99.2 Million - $118 Million	-2,131,535 Reduced 8.52%	22,899,251 $1.2 Billion
Q1 2022 May 16, 2022	BUY	$45.75 - $56.69 $89.5 Million - $111 Million	1,957,061 Added 8.48%	25,030,786 $1.3 Billion
Q4 2021 Feb 14, 2022	SELL	$41.32 - $61.25 $191 Million - $283 Million	-4,626,885 Reduced 16.7%	23,073,725 $1.36 Billion
Q3 2021 Nov 15, 2021	SELL	$39.25 - $50.42 $86.2 Million - $111 Million	-2,196,247 Reduced 7.35%	27,700,610 $1.19 Billion
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $23.8 Million - $26.9 Million	661,754 Added 2.26%	29,896,857 $1.17 Billion
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $27.9 Million - $31.5 Million	834,177 Added 2.94%	29,235,103 $1.06 Billion
Q4 2020 Feb 09, 2021	SELL	$33.47 - $42.56 $33.3 Million - $42.3 Million	-994,783 Reduced 3.38%	28,400,926 $1.05 Billion
Q3 2020 Nov 05, 2020	BUY	$31.75 - $37.25 $27.9 Million - $32.8 Million	879,376 Added 3.08%	29,395,709 $1.08 Billion
Q2 2020 Aug 13, 2020	BUY	$30.12 - $36.54 $21.7 Million - $26.3 Million	718,901 Added 2.59%	28,516,333 $932 Million
Q1 2020 May 14, 2020	BUY	$27.03 - $38.62 $751 Million - $1.07 Billion	27,797,432 New	27,797,432 $907 Million

Others Institutions Holding PFE

# of Institutions

3,256

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $140B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Pfizer Inc Transaction History